Drucker commented: GLP1 [drugs] have given us so many wonderful results, but tackling these very challenging brain disorders has been disappointing There was a hope that we would see some benefit, and we didnt. From the Alzheimers Drug Discovery Foundation (ADDF), Howard Fillit, MD, emphasized that even negative trials move the field forward, pointing to the need to target the broader pathobiology of Alzheimers and to consider preventive or combination approaches informed by biomarker profiles
But millions are now taking these drugs far beyond those boundaries
These drugs leapt from clinics to culture, from endocrinology to aspiration
The irony is that the weight loss theyre chasing for shape or aesthetics can be undermined by losing the very muscle that defines that shape without structured support
You start at 3 mg daily for 30 days
However, making a habit of early injections is not recommended because it can lead to drug accumulation and increased side effects